Packaging and plastics manufacturer Cardia Bioplastics has secured European patent protection for its bioplastics technology.
A subsidiary of SECOS Group Limited, Cardia received a patent for its compostable resin formulations and production processes.
Nine new Cardia Compostable, Biohybrid and PPC-starch technology patents have been granted in 2015. These new patents expand Cardia Bioplastics growing intellectual property portfolio of 11 patent families, with 28 patents so far granted in Europe, USA, Australia, China, Japan, New Zealand and South Africa, and 39 more patents pending registration. The patents protect the composition formulations, manufacturing processes and application technology invented by Cardia’s research and development team.
The patents protect the intellectual property of the company and support the technical differentiation of its Cardia Compostable and lower carbon footprint Cardia Biohybrid products.
Cardia’s compostable resins are certified biodegradable and compostable to international standards and used in a variety of applications from films, bags and moulded products to waste management items.
The biodegradable and compostable plastics market is projected to grow due to increased government regulation of environmental issues and waste management. Organic waste diversion is being implemented around the world using compostable waste management bags.
Markets and Markets Research Group predicts the global biodegradable and compostable plastics market to be worth more than US$3.4 billion by 2020.
